Vaxxinity
Vaxxinity, Inc. is a U.S.-based, clinical stage biotechnology company, that aims to democratize health by bringing the efficiency of vaccines to chronic diseases. Vaxxinity has a proprietary technology platform that has enabled the innovation of synthetic peptide vaccines designed to treat and prevent chronic diseases, including Alzheimer's, Parkinson's, migraine, and hypercholesterolemia, as well as infectious diseases, including COVID-19. Vaxxinity has designed its pipeline to achieve a historic global impact on human health.
Domain
vaxxinity.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$9.3M
Founded
2018
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does Vaxxinity use?+
Vaxxinity uses 19 technologies including Google Analytics, Google Tag Manager, WordPress.
What industry is Vaxxinity in?+
Vaxxinity operates in the Biotechnology industry.
Where is Vaxxinity based?+
Vaxxinity is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026